Patents by Inventor Dokeun KIM

Dokeun KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Display panel and method of fabricating the same
    Patent number: 12205963
    Abstract: A display panel includes: a base layer; a signal line disposed on the base layer, the signal line including: a first layer including aluminum; and a second layer directly disposed on the first layer, the second layer including a niobium-titanium alloy; a first thin film transistor connected to the signal line; a second thin film transistor disposed on the base layer; a capacitor electrically connected to the second thin film transistor; and a light emitting element electrically connected to the second thin film transistor.
    Type: Grant
    Filed: June 17, 2022
    Date of Patent: January 21, 2025
    Assignee: Samsung Display Co., Ltd.
    Inventors: Hyuneok Shin, Kyeongsu Ko, Sanggab Kim, Hongsick Park, Sangwoo Sohn, Dokeun Song, Sangwon Shin, Sukyoung Yang, Dongmin Lee
  • ATTENUATED MUMPS VACCINE AND USES THEREOF
    Publication number: 20240316180
    Abstract: The present invention relates to an attenuated mumps virus and a live vaccine comprising the same. The attenuated mumps virus vaccine of the present invention can be effectively used for additional vaccination to control the occurrence of breakthrough infection and the epidemic of mumps due to differences in genotypes of existing vaccine strains and epidemic strains and decreased immunity.
    Type: Application
    Filed: November 21, 2023
    Publication date: September 26, 2024
    Inventors: Tae-young LEE, Seo Yeon KIM, Hyeran WON, You-Jin KIM, Dokeun KIM
  • PLANT-BASED COVID-19 VARIANT RECOMBINANT SPIKE PROTEIN EXPRESSION VECTOR AND RECOMBINANT PROTEIN USING SAME
    Publication number: 20240316184
    Abstract: The present invention relates to a plant-based COVID-19 variant recombinant spike protein expression vector, and a recombinant protein using the expression vector, wherein a plant expression system is used such that the recombinant protein does not have the disadvantages of animal-derived recombinant proteins and exhibits an excellent SARS coronavirus 2 prevention and treatment effect, and thus can be effectively utilized as a safe composition for preventing and treating COVID-19.
    Type: Application
    Filed: July 19, 2022
    Publication date: September 26, 2024
    Applicant: BioApplications Inc.
    Inventors: Eun-Ju SOHN, Bo-Hwa CHOI, Hyangju KANG, Kyungmin MIN, Minhee PARK, Nam Hyung KIM, Daniel KIM, Yoo-Kyoung LEE, Byung-Chul KIM, Heeji LIM, Sundong JANG, Kwangwook KIM, Soo Ji KIM, Dokeun KIM, You-Jin KIM, Jung-Ah LEE, Woo-Jung PARK